PUBLISHER: Fortune Business Insights Pvt. Ltd. | PRODUCT CODE: 2128000
PUBLISHER: Fortune Business Insights Pvt. Ltd. | PRODUCT CODE: 2128000
The global biopsy forceps market was valued at USD 411.4 million in 2025 and is projected to grow from USD 437.5 million in 2026 to USD 683.2 million by 2034, registering a CAGR of 5.7% during the forecast period (2026-2034). The market growth is primarily driven by increasing gastrointestinal (GI) disease diagnosis, rising cancer screening programs, growing adoption of endoscopic procedures, and advancements in endoscopy technologies. In 2025, North America dominated the global market with a 46.94% market share, supported by advanced healthcare infrastructure and high procedural volumes.
Biopsy forceps are specialized medical instruments used during endoscopic procedures to obtain tissue samples for pathological examination. These devices play a critical role in diagnosing gastrointestinal disorders, inflammatory diseases, infections, precancerous lesions, and various forms of cancer. Growing awareness regarding early disease detection and increasing demand for minimally invasive diagnostic procedures continue to support market expansion globally.
Integration with Advanced Endoscopy Systems Emerging as a Key Trend
One of the most significant trends influencing the biopsy forceps market is the integration of tissue sampling tools with advanced endoscopy ecosystems. Modern endoscopy platforms increasingly combine high-definition imaging, artificial intelligence-assisted lesion detection, enhanced visualization technologies, and compatible biopsy devices.
These technological advancements allow physicians to identify suspicious lesions more accurately and improve tissue acquisition efficiency. The launch of advanced systems such as Olympus Corporation's EVIS X1 platform has further strengthened demand for high-performance biopsy forceps that can operate seamlessly with next-generation endoscopic equipment.
Rising Cancer Screening and GI Diagnostic Procedures Driving Market Growth
The growing incidence of colorectal cancer, gastric cancer, inflammatory bowel disease, Barrett's esophagus, and other gastrointestinal disorders is significantly increasing demand for biopsy procedures. Screening programs worldwide are encouraging earlier detection of cancerous and precancerous conditions, resulting in a higher volume of tissue sampling procedures.
The increasing number of colonoscopies and upper gastrointestinal examinations is directly supporting biopsy forceps adoption. As endoscopic imaging technologies continue to improve, physicians are detecting more suspicious lesions that require pathological confirmation, further fueling market growth.
Pricing Pressure Limiting Market Expansion
Despite strong demand, pricing pressure remains a major restraint for market participants. Hospitals, ambulatory surgery centers (ASCs), and healthcare providers are seeking to balance infection control requirements with procedural cost efficiency.
The availability of lower-cost disposable products from regional manufacturers has intensified competition, creating pressure on pricing strategies. These factors may slow adoption in cost-sensitive healthcare facilities, particularly in developing regions.
Growing Demand for Disposable Forceps Creating New Opportunities
The shift toward single-use medical devices is creating substantial growth opportunities for biopsy forceps manufacturers. Disposable biopsy forceps eliminate reprocessing requirements, reduce cross-contamination risks, and ensure consistent performance across procedures.
Healthcare providers are increasingly favoring disposable instruments to improve infection prevention and workflow efficiency. Additionally, advancements in precision tissue acquisition technologies are opening opportunities for manufacturers to develop innovative biopsy devices capable of collecting higher-quality tissue samples from difficult-to-access lesions.
Workforce Shortages Remain a Significant Challenge
A shortage of skilled endoscopists, technicians, and trained healthcare professionals continues to challenge market growth. In many emerging economies, insufficient numbers of trained specialists restrict the volume of diagnostic and interventional endoscopic procedures.
Even in developed countries, increasing demand for cancer screening programs often exceeds workforce capacity, leading to longer waiting times and reduced procedural throughput. These workforce limitations may hinder the full growth potential of the biopsy forceps market during the forecast period.
Segment Analysis
Based on product type, the market is segmented into flexible biopsy forceps and rigid biopsy forceps. The flexible biopsy forceps segment dominated the market in 2025 due to its extensive use in gastrointestinal, pulmonary, biliary, and colorectal endoscopic procedures. The rigid biopsy forceps segment is expected to grow at a CAGR of 4.1% through 2034.
By usability, the market is categorized into disposable and reusable biopsy forceps. The disposable segment accounted for the largest market share in 2025 and is expected to hold 69.9% of the market in 2026. Growing focus on infection control and procedural efficiency continues to drive demand for disposable products. The reusable segment is projected to grow at a CAGR of 3.8% during the forecast period.
Based on application, gastrointestinal endoscopy remained the leading segment in 2025 and is projected to account for 56.1% of the market in 2026. Rising colorectal cancer incidence and expanding screening programs continue to support segment growth. The bronchoscopy segment is expected to expand at a CAGR of 5.5% through 2034.
By end user, hospitals and ambulatory surgery centers (ASCs) dominated the market in 2025 and are forecast to hold 55.5% market share in 2026. The diagnostic and endoscopy centers segment is projected to register the fastest growth with a CAGR of 6.8%.
North America remained the largest regional market, reaching USD 193.1 million in 2025. High procedural volumes, strong healthcare infrastructure, and widespread adoption of advanced endoscopy systems continue to support regional leadership. The U.S. market is projected to reach USD 183.9 million in 2026, representing approximately 42.0% of global revenues.
Europe is expected to reach USD 96.2 million in 2026, growing at a CAGR of 5.4%. Well-established healthcare systems and increasing use of diagnostic endoscopy support regional growth.
Asia Pacific is projected to reach USD 90.7 million in 2026, driven by rising cancer prevalence, expanding healthcare infrastructure, and growing access to endoscopic diagnosis across China, Japan, India, and South Korea. China alone is expected to account for USD 47.6 million in 2026, making it one of the fastest-growing national markets.
Competitive Landscape
The global biopsy forceps market is highly competitive, led by major companies such as Olympus Corporation, Boston Scientific Corporation, Cook, CONMED Corporation, STERIS, Medtronic, Micro-Tech (Nanjing) Co., Ltd., KARL STORZ SE & Co. KG, Richard Wolf GmbH, and ENDO-FLEX GmbH.
Leading manufacturers continue investing in product innovation, strategic partnerships, acquisitions, and advanced endoscopy solutions to strengthen market presence. Recent developments include FDA clearances for next-generation endoscopes, AI-assisted imaging technologies, and innovative biopsy devices designed to improve tissue acquisition and diagnostic accuracy.
Conclusion
The global biopsy forceps market is expected to grow steadily from USD 411.4 million in 2025 to USD 437.5 million in 2026, reaching USD 683.2 million by 2034. Rising gastrointestinal disease burden, increasing cancer screening initiatives, technological advancements in endoscopy systems, and growing demand for disposable biopsy devices will continue to drive market expansion. Although pricing pressures and workforce shortages remain challenges, ongoing innovation and expanding access to minimally invasive diagnostic procedures are expected to support long-term market growth worldwide.
Segmentation By Product Type, Usability, Application, End-user, and Region
By Product Type * Flexible Biopsy Forceps
By Usability * Disposable
By Application * Gastrointestinal Endoscopy
By End-user * Hospitals & ASCs
By Region * North America (By Product Type, Usability, Application, End-user, and Country)